Wegovy stomach vs thigh: does the injection site actually matter?

Free consultation reviewed the same day by a GPhC-registered Independent Prescriber — a real clinician reads your answers, not software.
Prescription issued the same day if you are clinically suitable, with no hidden consultation or prescription fees.
Order before 12pm Monday to Friday and your treatment is dispatched the same day, arriving free the next working day via DPD in plain, unbranded packaging.
Priority aftercare seven days a week, our clinical team is available between doses, not just at checkout.

The short answer is that both the stomach and thigh are licensed injection sites for Wegovy, and the medicine works the same way regardless of which you choose — absorption rates are broadly equivalent across all approved sites. That said, where you inject affects comfort, bruising and how easy self-administration feels week to week. Wegovy (semaglutide) is a prescription-only medicine; a GPhC-registered prescriber assesses whether it is clinically right for you before any treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence and our prescribers actually say about injection-site choice

The myth: one site is stronger, one site is weaker

A question our prescribers hear most weeks is whether injecting into the stomach gives Wegovy a faster or stronger effect than the thigh. It is an understandable assumption (many medicines do behave differently depending on how close they are injected to major blood vessels) but for semaglutide the clinical picture is more reassuring. The Wegovy SmPC published on the electronic Medicines Compendium confirms that subcutaneous injection into the abdomen, thigh or upper arm produces comparable systemic exposure. In practical terms, your body absorbs the medicine to broadly the same degree whichever licensed site you use.

Where the myth comes from is reasonable enough: some people report nausea feeling more pronounced on certain weeks, and they associate it with the site they used. In reality, nausea tracks dose changes far more closely than it tracks geography. The 0.25 mg starting dose, the first pen's job being to let your system adjust before any therapeutic effect kicks in, is the bigger driver of early side effects. Site choice is mostly a conversation about comfort and practicality.

The NHS patient information for semaglutide confirms the three approved sites and notes that rotating between them reduces the chance of localised skin reactions.

Stomach vs thigh: what actually differs in practice

The comparison below covers the practical differences reported by patients and noted in prescribing guidance. No site is clinically superior for weight loss.

FactorAbdomen (stomach)Thigh
Ease of self-injectionEasy to reach and see for most peopleEasy to reach when seated; clothing may need adjusting
Tissue depthTypically good subcutaneous layer; avoid 5 cm around the navelOuter thigh preferred; less tissue in very lean individuals
Bruising and tendernessMore common in the periumbilical area if rotation is poorLower bruising rates reported by many patients
Injection visibilityStraightforward to see and pinch the skinEasy when seated; harder to see the back of the thigh
Licensed by the SmPCYesYes

People who carry most of their weight around the abdomen sometimes find the stomach site more comfortable because there is more subcutaneous tissue to work with. Others find the thigh site less tender day to day, particularly if they have a lighter abdominal skin layer. Neither preference is wrong, and switching between the two from week to week is fine as long as you avoid injecting into exactly the same spot twice running. If you want to read about how Wegovy sits alongside other GLP-1 options, the Wegovy vs other GLP-1 medicines page covers the broader landscape.

Rotation: the rule that matters more than the site you pick

Whichever site you prefer, consistent rotation within that area is the habit that protects your skin. Repeatedly injecting into the same small patch can cause lipohypertrophy, a localised thickening of the tissue that slows absorption and makes injections lumpier and more uncomfortable over time. The solution is simple: move the injection point at least a few centimetres from last week's spot, either by tracking locations or using a rough mental grid across the injection zone.

The upper arm is a third licensed site, useful if a partner or carer is helping with injections, though most people self-inject into the abdomen or thigh. Avoid broken, irritated, or scarred skin and never inject into a site that is bruised or tender from a previous injection. Full rotation guidance is in the Patient Information Leaflet supplied with your pen, always read that alongside anything written here. For a broader overview of how semaglutide works and what to expect from treatment, the Wegovy treatment page is the place to start. Those considering how Wegovy compares with Ozempic, which is also semaglutide but licensed exclusively for type 2 diabetes and not for weight loss, can read the Wegovy vs Ozempic page for a clear breakdown of the licensing distinction.

Which site is right for you? That is a clinical conversation

Skin conditions, previous surgery, body composition and personal dexterity all affect which injection site will work best for a given person. Someone with abdominal scarring from a previous procedure, for example, will need to think carefully about whether the stomach is practical. Someone who finds it hard to pinch enough skin at the thigh may do better using the abdomen. These are exactly the details a prescriber weighs when they review your consultation.

If you are exploring Wegovy for the first time, or comparing it with alternatives like Saxenda or reading up on the wider Wegovy comparison pages, the starting point is always a clinical assessment. For guidance on finding a legitimate supplier, the how to buy Wegovy online safely page explains what to check, including verifying any online pharmacy on the GPhC register. At nume, every consultation is reviewed by a named GPhC-registered prescriber the same day. Speak to our prescribers to find out whether Wegovy is suitable for you and to get a clear, personalised steer on administration from the outset. Start your free consultation here.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions